Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

BioLight to Distribute Laser Eye Surgery System in Hong Kong, Macao

Facebook Twitter LinkedIn Email
BioLight Life Sciences Investments Ltd. will distribute IOPtima’s IOPtiMate laser eye surgery system in Hong Kong and Macao, with a purchase commitment of at least nine systems.

IOPtiMate is based on CO2 laser technology and enables filtration surgery, which treats glaucoma without penetrating the inner part of the eyeball. Compared with alternatives, this allows substantial reductions in postoperative complications and use of eye drops, according to BioLight.

A leading medical center in Hong Kong recently purchased the system, while another is using IOPtiMate on a trial basis.

“Entering into a strategic distribution agreement in Hong Kong and Macao is an additional significant advancement in our plan to penetrate developing markets in Asia, where there is no available solution for a large population of patients,” said BioLight CEO Suzana Nahum-Zilberberg.

Earlier this year BioLight and IOPtima reached a distribution agreement for China with a purchase commitment of 100 systems.

For more information, visit

Mar 2015
The branch of medicine involved in the study of the anatomy, functions, diseases and treatments of the eye.
BusinessAsia-PacificophthalmologylasersBiophotonicslaser eye surgeryCO2 lasersBioLight Life Sciences InvestmentsIOPtimaAsia-Pacific Special Sectionlight speedRapidScan

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.